Independent Director · X4 Pharmaceuticals, Inc (XFOR)

Gary J. Bridger, Ph.D — X4 Pharmaceuticals Director Compensation (2025)

Fiscal year 2025 director compensation for Gary J. Bridger, Ph.D at X4 Pharmaceuticals, Inc. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 20, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Gary J. Bridger, Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Gary’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Gary J. Bridger, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

X4 Pharmaceuticals Director Compensation Table · all 4 fiscal years held
In US dollars, as X4 Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$58,560$6,210—$0$64,770
FY2024$58,000$46,800—$0$104,800
FY2023$35,000$112,050—$0$147,050
FY2021$37,000—$42,233—$79,233

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: X4 Pharmaceuticals, Inc DEF 14A filed March 20, 2026, accession 0001501697-26-000031, and prior-year filings. Open the filing on EDGAR.

How this page was built: the X4 Pharmaceuticals, Inc filed document, accession 0001501697-26-000031. Every figure is read from that document and cited to the page and table it appears in. Filed March 20, 2026.

Get the X4 Pharmaceuticals Board Governance Report

$64,770 Gary J. Bridger, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of March 20, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

X4 Pharmaceuticals pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation

The rest of the X4 Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Adam R. Craig, M.D., Ph.D., M.B.AChair of the Board—
Françoise De CraeckerIndependent Director$57,101
Michael S. WyzgaLead Independent Director$89,147
Murray W. Stewart, M.DIndependent Director$62,710

The full X4 Pharmaceuticals compensation record

free company brief

This page is one director within X4 Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Order XFOR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report